Blog
Whitestone REIT Shareholders Approve AREG Merger, Reject Executive Pay Plan
Key Points
- Interested in Whitestone REIT? Here are five stocks we like better.
- Whitestone REIT shareholders approved the company’s merger with AREG Wizard Intermediate LP at a virtual special
Unum Group Cuts Long-Term Care Risk With $3.8B Reinsurance Deal
Key Points
- Interested in Unum Group? Here are five stocks we like better.
- Unum Group agreed to reinsure an additional $3.8 billion of long-term care statutory reserves with Fortitude Re
Teva Pharmaceutical Industries’ Anti-IL-15 Antibody Shows Promise in Vitiligo Study
Key Points
- Interested in Teva Pharmaceutical Industries Ltd.? Here are five stocks we like better.
- Teva’s anti-IL-15 antibody showed encouraging 24-week results in a phase 1b vitiligo study
Dr. Reddy's Laboratories Flags Semaglutide Supply Delay, Says No Recall Risk
Key Points
- Interested in Dr. Reddy's Laboratories Ltd? Here are five stocks we like better.
- Dr. Reddy’s Laboratories said a scale-up issue involving the API for its semaglutide injection will
Planet Labs PBC Shareholders Back Directors, KPMG and Pay Plan at Annual Meeting
Key Points
- Interested in Planet Labs PBC? Here are five stocks we like better.
- Planet Labs shareholders backed all three management proposals at the 2026 annual meeting, including the
MasTec Bets Big on AI Infrastructure With $1.65B Superior Group Deal
Key Points
- Interested in MasTec, Inc.? Here are five stocks we like better.
- MasTec is buying Superior Group for about $1.65 billion, with the deal structured as $1.175 billion in cash, $475
Element Solutions Lands $14.5B Solstice Deal as AI Data Center Demand Booms
Solstice Advanced Materials said it has agreed to acquire Element Solutions (NYSE:ESI) in a cash-and-stock transaction valued at approximately
Equifax Expands in Mexico With $750 Million Círculo de Crédito Deal
Key Points
- Interested in Equifax, Inc.? Here are five stocks we like better.
- Equifax has agreed to buy Mexico’s Círculo de Crédito for an enterprise value of $750 million, marking a major
3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
Key Points
- Interested in VanEck Rare Earth and Strategic Metals ETF? Here are five stocks we like better.
- China's rare-earth dominance stems from decades of investment in refining and processing
Dycom Industries Says Fiber, Data Center Demand Gives Backlog ‘Staying Power’
Key Points
- Interested in Dycom Industries, Inc.? Here are five stocks we like better.
- Dycom sees lasting demand from fiber, long-haul networks and data center projects, with CEO Dan Peyovich
Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
Key Points
- Interested in Microsoft Corporation? Here are five stocks we like better.
- Microsoft is routing some Excel and Outlook prompts to its own MAI models instead of OpenAI or Anthropic to
Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
Key Points
- Interested in Delta Air Lines, Inc.? Here are five stocks we like better.
- Delta Air Lines reported strong Q2 2026 results with revenue up 30.3% and raised guidance, prompting 27
Why "Big Short" Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks
Key Points
- Interested in Flutter Entertainment PLC? Here are five stocks we like better.
- Michael Burry recently bought shares of DraftKings and Flutter Entertainment, betting on a recovery in
Capri Charts Post-Versace Comeback With Michael Kors Revamp, Jimmy Choo Growth
Key Points
- Interested in Capri Holdings Limited? Here are five stocks we like better.
- Capri is refocusing after selling Versace, with management now concentrating on Michael Kors and Jimmy
Clarivate to Sell Life Sciences Unit to Altaris for $600M, Refocus Core Business
Key Points
- Interested in Clarivate PLC? Here are five stocks we like better.
- Clarivate will sell substantially all of its Life Sciences & Healthcare segment to Altaris for $600 million, with
Chewy Annual Meeting: Directors Elected, Deloitte Ratified and Pay Vote Approved
Key Points
- Interested in Chewy? Here are five stocks we like better.
- At Chewy’s 2026 Annual Meeting, shareholders elected all five Class I director nominees to three-year terms ending at the
AstraZeneca Updates 2030 Sustainability Goals as AI and Emissions Cuts Take Center Stage
Key Points
- Interested in Astrazeneca Plc? Here are five stocks we like better.
- AstraZeneca updated its 2030 sustainability targets, lowering its Scope 3 emissions goal to a 35% reduction from
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
Key Points
- Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better.
- Vertex Pharmaceuticals agreed to buy Crinetics Pharmaceuticals for $85 per share in cash
Veritone Shareholders Back Share Increase, CEO Awards as Debt Questions Loom
Key Points
- Interested in Veritone, Inc.? Here are five stocks we like better.
- Veritone shareholders approved all six proposals at the 2026 annual meeting, including re-electing two directors
Veritone Maps AI Growth Push as Oracle Partnership Targets Cost Savings
Key Points
- Interested in Veritone, Inc.? Here are five stocks we like better.
- Veritone outlined a broad AI strategy centered on turning unstructured data like video, audio and documents into
Vera Therapeutics Wins FDA Approval for TRUTAKNA in IgA Nephropathy, Sets Launch
Key Points
- Interested in Vera Therapeutics, Inc.? Here are five stocks we like better.
- Vera Therapeutics won accelerated FDA approval for TRUTAKNA (atacicept-vymj) to treat adults with primary
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
Key Points
- Interested in Turn Therapeutics Inc.? Here are five stocks we like better.
- Turn Therapeutics refined the stage two design of its GX-03 phase II eczema trial after an interim
TruBridge Stockholders Approve IKS Merger at Special Meeting
Key Points
- Interested in TruBridge, Inc.? Here are five stocks we like better.
- TruBridge stockholders approved the company’s merger agreement with Inventurus Knowledge Solutions Inc. (IKS)
Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
Key Points
- Interested in Starbucks Corporation? Here are five stocks we like better.
- Starbucks is building internal AI tools to replace Microsoft and IBM software, targeting cuts to its $400
Tarsus Pharmaceuticals Enters Retina Market With iRenix Deal, Adds IRX-101 to Pipeline
Key Points
- Interested in Tarsus Pharmaceuticals, Inc.? Here are five stocks we like better.
- Tarsus Pharmaceuticals closed its acquisition of iRenix Medical, adding IRX-101 to its pipeline and